logo-loader
AIM:TILS NASDAQ:TLSA

Tiziana Life Sciences PLC

Market:
AIM
Market Cap:
£268.58 m
Price
161.40 GBX
Change
7.60%
52 weeks high
172.50
52 weeks low
23.50

In brief

Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biotechnology company that specializes in the developing transformative therapies for inflammatory diseases and cancer related to the liver. Our clinical pipeline includes drug assets for NASH, Crohn's, and hepatocellular carcinoma. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.